PCT/2001/45 - World Intellectual Property Organization
PCT/2001/45 - World Intellectual Property Organization
PCT/2001/45 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>45</strong>/<strong>2001</strong><br />
8 Nov/nov <strong>2001</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> <strong>2001</strong>1<br />
TJ TM TR TT TZ UA UG US UZ VN YU ZA<br />
ZW.<br />
(84) AP (GH GM KE LS MW SD SL SZ TZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF<br />
BJ CF CG CI CM GA GN GW ML MR NE<br />
SN TD TG).<br />
(51) 7 A61K 31/22, 31/23, 31/215<br />
(11) WO 01/82928 (13) A1<br />
(21) <strong>PCT</strong>/US01/13955<br />
(22) 1 May/mai <strong>2001</strong> (01.05.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/200,980 1 May/mai 2000 US<br />
(01.05.2000)<br />
(43) 8 Nov/nov <strong>2001</strong> (08.11.<strong>2001</strong>)<br />
(54) USE OF MEDIUM CHAIN TRIGLYC-<br />
ERIDES FOR THE TREATMENT AND<br />
PREVENTION OF ALZHEIMER’S<br />
DISEASE AND OTHER DISEASES<br />
RESULTING FROM REDUCED NEU-<br />
RONAL METABOLISM<br />
UTILISATION DE TRIGLYCERIDES<br />
DE CHAINE MOYENNE POUR TRAI-<br />
TER ET PREVENIR LA MALADIE<br />
D’ALZHEIMER ET D’AUTRES MALA-<br />
DIES PROVOQUEES PAR UN META-<br />
BOLISME NEURONAL DIMINUE<br />
(71, 72) HENDERSON, Samuel, T. [US/US];<br />
2110 West 10th Avenue, Apt. 203, Broomfield,<br />
CO 80020 (US).<br />
(74) SWANSON, Barry, J. et al. / etc.; Swanson<br />
& Bratschun, L.L.C., Suite 330, 17<strong>45</strong> Shea<br />
Center Drive, Highlands Ranch, CO 80126<br />
(US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KP KR KZ LC<br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT TZ UA UG US<br />
UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/35<br />
(11) WO 01/82929<br />
(21) <strong>PCT</strong>/FR01/01314<br />
(13) A2<br />
(22) 27 Apr/avr <strong>2001</strong> (27.04.<strong>2001</strong>)<br />
(25) fr (26) fr<br />
(30) 00/05524 28 Apr/avr 2000<br />
(28.04.2000)<br />
FR<br />
(43) 8 Nov/nov <strong>2001</strong> (08.11.<strong>2001</strong>)<br />
(54) EPICHATECHIN AS NO-SYNTHASE<br />
INHIBITOR AND USES<br />
EPICHATECHINE COMME INHIBI-<br />
TEUR DE NO-SYNTHASE ET UTILI-<br />
SATIONS<br />
(71) L’OREAL [FR/FR]; 14, rue Royale,<br />
F-75008 Paris (FR).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) CALS-GRIERSON, Marie-Madeleine<br />
[FR/FR]; 5, chemin de l’Ermitage, F-92190<br />
Meudon (FR).<br />
(74) GALUP, Cédric; L’Oréal/D.P.I., 6, rue<br />
Bertrand Sincholle, F-92585 Clichy Cedex<br />
(FR).<br />
(81) BR CA JP US.<br />
(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE TR).<br />
(51) 7 A61K 31/4155, A61P 31/04, C07D 409/04<br />
(11) WO 01/82930 (13) A1<br />
(21) <strong>PCT</strong>/US01/14439<br />
(22) 2 May/mai <strong>2001</strong> (02.05.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/201,988 3 May/mai 2000 US<br />
(03.05.2000)<br />
(43) 8 Nov/nov <strong>2001</strong> (08.11.<strong>2001</strong>)<br />
(54) PYRAZOLE ANTIMICROBIAL<br />
AGENTS<br />
AGENTS MICROBIENS A BASE DE<br />
PYRAZOLE<br />
(71) TULARIK INC. [US/US]; Two Corporate<br />
Drive, South San Francisco, CA 94080 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) LI, Leping [CN/US]; 2100 Davis Drive,<br />
Burlingame, CA 94010 (US). CHEN, Xiaoqi<br />
[CN/US]; 640 Hobart Avenue, San Mateo,<br />
CA 94402 (US). CUTLER, Serena, T.<br />
[US/US]; 449 Hawthorne Avenue, #3, Palo<br />
Alto, CA 94301 (US).<br />
(74) MANN, Jeffry, S.; Townsend and Townsend<br />
and Crew LLP, Two Embarcadero Center,<br />
Eight Floor, San Francisco, CA 94111 (US)<br />
et al. / etc.<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KP KR KZ LC<br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT TZ UA UG US<br />
UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/52, 31/44, 31/135<br />
(11) WO 01/82931<br />
(21) <strong>PCT</strong>/US01/10871<br />
(13) A1<br />
(22) 3 Apr/avr <strong>2001</strong> (03.04.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 09/561,391 27 Apr/avr 2000<br />
(27.04.2000)<br />
US<br />
(43) 8 Nov/nov <strong>2001</strong> (08.11.<strong>2001</strong>)<br />
(54) (+) NALOXONE AND EPINEPHRINE<br />
COMBINATION THERAPY<br />
THERAPIE A BASE D’UNE COM-<br />
BINAISON DE (+) NALOXONE<br />
D’EPINEPHRINE<br />
ET<br />
(71) SURE MEDICAL, INC. [US/US]; Suite<br />
200, 10150 Highland Manor Drive, Tampa,<br />
FL 33610 (US).<br />
(72) CAFFREY, James, L.; 1904 Red Oak Drive,<br />
Burleson, TX 76028 (US).<br />
(74) GUNTER, Charles, D., Jr.; Bracewell<br />
& Patterson, L.L.P., Suite 1600, 201 Main<br />
Street, Fort Worth, TX 76102 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EE ES FI GB GD GE GH GM HR<br />
HU ID IL IN IS JP KE KG KP KR KZ LC<br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PL PT RO RU SD SE<br />
SG SI SK SL TJ TM TR TT TZ UA UG UZ<br />
VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).<br />
(51) 7 A61K 31/661, 31/6615, 31/662, 31/7084,<br />
31/706, 31/7076<br />
(11) WO 01/82932 (13) A2<br />
(21) <strong>PCT</strong>/US01/13931<br />
(22) 30 Apr/avr <strong>2001</strong> (30.04.<strong>2001</strong>)<br />
(25) en (26) en<br />
(30) 60/200,843 1 May/mai 2000 US<br />
(01.05.2000)<br />
(30) 60/230,263 6 Sep/sep 2000 US<br />
(06.09.2000)<br />
(30) 60/233,025 15 Sep/sep 2000 US<br />
(15.09.2000)<br />
(43) 8 Nov/nov <strong>2001</strong> (08.11.<strong>2001</strong>)<br />
(54) METHODS AND COMPOSITIONS FOR<br />
ENHANCING CELLULAR FUNCTION<br />
THROUGH PROTECTION OF TISSUE<br />
COMPONENTS<br />
METHODES ET COMPOSITIONS DES-<br />
TINEES A AMELIORER LA FONC-<br />
TION CELLULAIRE PAR LA PRO-<br />
TECTION DE COMPOSANTS TISSU-<br />
LAIRES<br />
(71) HEALTHPARTNERS RESEARCH<br />
FOUNDATION [US/US]; 8100 34th Avenue<br />
South, Minneapolis, MN 55440-1524<br />
(US).<br />
(72) FREY, William, H., II.; 4800 Centerville<br />
Road, Apt. 216, White Bear Lake, MN 55127<br />
(US). FAWCETT, John, Randall; 928 Grand<br />
Avenue, # 305, St. Paul, MN 55105 (US).<br />
THORNE, Robert, Gary; 2610 Fremont Avenue<br />
South #106, Minneapolis, MN 55408<br />
(US). CHEN, Xueqing; 1166 Fifield Avenue,<br />
Apt. S2, St. Paul, MN 55108 (US).<br />
(74) FORREST, Peter, R.; Gray, Plant, Mooty,<br />
Mooty & Bennett, P.A., P.O. Box 2906, Minneapolis,<br />
MN 55402-2906 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CR CU CZ DE DK DM<br />
DZ EE ES FI GB GD GE GH GM HR HU<br />
ID IL IN IS JP KE KG KP KR KZ LC LK<br />
LR LS LT LU LV MA MD MG MK MN MW<br />
MX MZ NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG UZ VN YU<br />
ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GW ML MR<br />
NE SN TD TG).